Flagship V VentureLabs Rx Fund, L.P.
Insider CIK 1724939 · CDAK 10% owner · EVLO 10% owner · RUBY 10% owner · SANA 10% owner · OMGA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 345,069 | — | $0 | 1,035,208 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,431,281 | — | $0 | 7,293,841 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 1,181,745 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 4,926,378 | — | $0 | 8,057,470 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 70,813 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,825,989 | — | $0 | 8,615,337 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-07 | 2023-06-08 | 22,760 | $6.24 | $142.0K | 1,380,277 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-07 | 2023-06-08 | 177,240 | $6.24 | $1.11M | 10,743,293 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-06 | 2023-06-08 | 181,461 | $6.31 | $1.15M | 10,920,533 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-06 | 2023-06-08 | 22,297 | $6.31 | $140.7K | 1,403,037 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-26 | 2023-05-26 | 9,330 | $6.23 | $58.1K | 1,425,334 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-26 | 2023-05-26 | 72,670 | $6.23 | $452.7K | 11,101,994 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-25 | 2023-05-26 | 13,127 | $6.35 | $83.4K | 1,434,664 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-25 | 2023-05-26 | 102,245 | $6.35 | $649.3K | 11,174,664 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-24 | 2023-05-26 | 39,580 | $6.57 | $260.0K | 1,447,791 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-24 | 2023-05-26 | 308,290 | $6.57 | $2.03M | 11,276,909 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 722,590 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 210,743 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 1,188,920 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 1,865,767 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 22,275,232 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 4,112,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 27,388,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 13,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,666 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 970,588 | — | $0 | 970,588 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,323,529 | — | $0 | 1,323,529 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 661,764 | $17.00 | $11.25M | 5,514,707 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 4,852,943 | — | $0 | 4,852,943 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 294,117 | $17.00 | $5.00M | 1,617,646 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 220,588 | $17.00 | $3.75M | 8,617,413 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 8,396,825 | — | $0 | 8,396,825 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 5,896,386 | — | $0 | 5,896,386 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,088,470 | — | $0 | 1,088,470 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 1,487,371 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 9,725,122 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 11,441,326 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 11,585,199 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 165,000 | $15.00 | $2.48M | 1,143,177 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 3,830,402 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 15,323,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 2,563,703 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 1,781,843 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 4,643,963 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 18,611,110 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 8,333,000 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 5,416,667 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 10,102,055 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 12,536,945 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-15 | 14,622,143 | — | $0 | 17,952,153 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 281,250 | $16.00 | $4.50M | 18,233,403 | SEC↗ |